Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT02786147 · ClinicalTrials.gov registry record
Identification and Referral of Women at Risk for Hereditary Breast/Ovarian Cancer
A clinical trial, sponsored by Emory University.
- Completed
- Registry status
- 665
- Enrollment target
NCT02786147: Completed study, sponsored by Emory University.
NCT02786147 is a clinical trial that has completed, run by Emory University. The registered enrollment target is 665 participants. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT02786147 has completed, sponsored by Emory University.
- COMPLETED
- Registry status
- 665 participants
- Enrollment target
Study Summary
The purpose of this study is to identify the most effective means of follow-up for women who screen positive on B-RST (Breast Cancer Genetics Referral Screening Tool) applied in the standard clinical setting of mammography, to maximize the number who are referred to and receive cancer genetic counseling services. The clinical utility of B-RST 3.0 will also be evaluated by determining the number seen who are appropriate for genetic testing, undergo genetic testing and are found to carry a hereditary cancer gene mutations with medical management implications for the patient and family. The long-term goal is to reduce the morbidity and mortality associated with hereditary causes of breast and ovarian cancer among patients seen in the Emory/Winship system.
Interventions
- OTHER Breast Cancer Genetics Referral Screening Tool 3.0
- OTHER Standard Handout
- OTHER Physician Notification
- OTHER Automatic Follow-Up by Genetic Counseling Staff
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 665 participants |
| Start Date | 2016-04 |
| Est. Completion | 2018-02-28 |
What the finished NCT02786147 record still lists
NCT02786147 is an observational study that tracks outcomes without assigning an intervention. The registered 665 participants enrollment target is mid-sized for trials with a published cap.
The record links to 0 conditions, and to 4 interventions - of which Breast Cancer Genetics Referral Screening Tool 3.0 is the first listed.
NCT02786147 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT02786147 about?
NCT02786147 is a clinical study titled "Identification and Referral of Women at Risk for Hereditary Breast/Ovarian Cancer". The purpose of this study is to identify the most effective means of follow-up for women who screen positive on B-RST (Breast Cancer Genetics Referral Screening Tool) applied in the standard clinical setting of mammography, to maximize the number who are referred to and receive cancer genetic counse...
What is the current status of trial NCT02786147?
This trial is currently completed. The enrollment target is 665 participants. The study started on 2016-04. Estimated completion is 2018-02-28.
What interventions are being tested in trial NCT02786147?
The interventions under investigation include: Breast Cancer Genetics Referral Screening Tool 3.0 (OTHER), Standard Handout (OTHER), Physician Notification (OTHER), Automatic Follow-Up by Genetic Counseling Staff (OTHER).
Who is sponsoring clinical trial NCT02786147?
This trial is sponsored by Emory University, which has 1,208 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT04064060 · 665 participants · Phase 3
A Study to Evaluate Long-term Safety in Participants Who Have Participated in Other Luspatercept (ACE-536) Clinical Trials
- NCT06328647 · 666 participants · NA
Quantra Point-of-Care Hemostasis Monitoring
- NCT06981078 · 666 participants · Phase 2
A Study to Assess the Efficacy and Safety of Verekitug in Participants With COPD
- NCT06607341 · 664 participants · NA
Community Engagement Alliance Against Disparities
Similar registry start date
- NCT05988463 · started 2027-01-01 · Phase 1
Dose-Escalation Study of Artesunate Patients With IPF
- NCT07219706 · started 2026-12-10 · NA
Dietary Fiber and Time Restricted Eating
- NCT02831335 · started 2026-12-01
Technical Development of Multi-Parametric Renocerebral MRI
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia